| Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder I Labuschagne, KL Phan, A Wood, M Angstadt, P Chua, M Heinrichs, ... Neuropsychopharmacology 35 (12), 2403-2413, 2010 | 594 | 2010 |
| Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ... The Lancet Neurology 16 (9), 701-711, 2017 | 286 | 2017 |
| The wisdom to know the difference: Strategy-situation fit in emotion regulation in daily life is associated with well-being SJ Haines, J Gleeson, P Kuppens, T Hollenstein, J Ciarrochi, ... Psychological Science 27 (12), 1651-1659, 2016 | 274 | 2016 |
| Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder S Dodhia, A Hosanagar, DA Fitzgerald, I Labuschagne, AG Wood, ... Neuropsychopharmacology 39 (9), 2061-2069, 2014 | 223 | 2014 |
| Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex CS Sripada, KL Phan, I Labuschagne, R Welsh, PJ Nathan, AG Wood International Journal of Neuropsychopharmacology 16 (2), 255-260, 2013 | 211 | 2013 |
| The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation M Papoutsi, I Labuschagne, SJ Tabrizi, JC Stout Movement Disorders 29 (5), 673-683, 2014 | 172 | 2014 |
| Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by oxytocin I Labuschagne, KL Phan, A Wood, M Angstadt, P Chua, M Heinrichs, ... International Journal of Neuropsychopharmacology 15 (7), 883-896, 2012 | 172 | 2012 |
| Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease JC Stout, R Jones, I Labuschagne, AM O'Regan, MJ Say, EM Dumas, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (7), 687-694, 2012 | 167 | 2012 |
| Oxytocin modulation of amygdala functional connectivity to fearful faces in generalized social anxiety disorder SM Gorka, DA Fitzgerald, I Labuschagne, A Hosanagar, AG Wood, ... Neuropsychopharmacology 40 (2), 278-286, 2015 | 154 | 2015 |
| MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1 M Flower, V Lomeikaite, M Ciosi, S Cumming, F Morales, K Lo, ... Brain 142 (7), 1876-1886, 2019 | 140 | 2019 |
| Compensation in preclinical Huntington's disease: evidence from the track-on HD study S Klöppel, S Gregory, E Scheller, L Minkova, A Razi, A Durr, RAC Roos, ... EBioMedicine 2 (10), 1420-1429, 2015 | 140 | 2015 |
| Oxytocin and brain activity in humans: a systematic review and coordinate-based meta-analysis of functional MRI studies SA Grace, SL Rossell, M Heinrichs, C Kordsachia, I Labuschagne Psychoneuroendocrinology 96, 6-24, 2018 | 121 | 2018 |
| Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial Huntington Study Group Reach2HD Investigators The Lancet Neurology 14 (1), 39-47, 2015 | 115 | 2015 |
| Task characteristics influence facial emotion recognition age-effects: A meta-analytic review. GS Hayes, SN McLennan, JD Henry, LH Phillips, G Terrett, PG Rendell, ... Psychology and aging 35 (2), 295, 2020 | 108 | 2020 |
| An introductory guide to conducting the Trier Social Stress Test I Labuschagne, C Grace, P Rendell, G Terrett, M Heinrichs Neuroscience & Biobehavioral Reviews 107, 686-695, 2019 | 98 | 2019 |
| Executive function in body dysmorphic disorder J Dunai, I Labuschagne, DJ Castle, M Kyrios, SL Rossell Psychological medicine 40 (9), 1541-1548, 2010 | 93 | 2010 |
| Brain regions showing white matter loss in Huntington’s disease are enriched for synaptic and metabolic genes P McColgan, S Gregory, KK Seunarine, A Razi, M Papoutsi, E Johnson, ... Biological psychiatry 83 (5), 456-465, 2018 | 91 | 2018 |
| Decision-making ability in current and past users of opiates: A meta-analysis K Biernacki, SN McLennan, G Terrett, I Labuschagne, PG Rendell Neuroscience & Biobehavioral Reviews 71, 342-351, 2016 | 84 | 2016 |
| The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease EB Johnson, EM Rees, I Labuschagne, A Durr, BR Leavitt, RAC Roos, ... Neuropsychologia 79, 138-146, 2015 | 65 | 2015 |
| The neurobiology of body dysmorphic disorder: A systematic review and theoretical model SA Grace, I Labuschagne, RA Kaplan, SL Rossell Neuroscience & Biobehavioral Reviews 83, 83-96, 2017 | 63 | 2017 |
Julie C. StoutProfessor, School of Psychological Science, Monash University, Victoria, AustraliaAdresse e-mail validée de monash.edu
